Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2026-01-07 @ 2:35 PM
Study NCT ID:
NCT00000658
Status:
COMPLETED
Last Update Posted:
2021-11-03
First Post:
1999-11-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization: